KR102469337B1 - Method for preparing antler extract and kyung-ok-go containing antler extract - Google Patents
Method for preparing antler extract and kyung-ok-go containing antler extract Download PDFInfo
- Publication number
- KR102469337B1 KR102469337B1 KR1020200188765A KR20200188765A KR102469337B1 KR 102469337 B1 KR102469337 B1 KR 102469337B1 KR 1020200188765 A KR1020200188765 A KR 1020200188765A KR 20200188765 A KR20200188765 A KR 20200188765A KR 102469337 B1 KR102469337 B1 KR 102469337B1
- Authority
- KR
- South Korea
- Prior art keywords
- antler
- extract
- present
- deer
- hours
- Prior art date
Links
- 210000003056 antler Anatomy 0.000 title claims abstract description 128
- 239000000284 extract Substances 0.000 title claims abstract description 104
- 238000000034 method Methods 0.000 title claims abstract description 26
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 20
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims abstract description 20
- 239000002253 acid Substances 0.000 claims abstract description 19
- 238000000605 extraction Methods 0.000 claims description 39
- 239000000706 filtrate Substances 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 230000032683 aging Effects 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 241000282994 Cervidae Species 0.000 abstract description 34
- 239000004480 active ingredient Substances 0.000 abstract description 26
- 229910052640 jadeite Inorganic materials 0.000 abstract description 20
- 230000003078 antioxidant effect Effects 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 9
- 230000036039 immunity Effects 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 53
- 239000000843 powder Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 238000001816 cooling Methods 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 6
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- BJHCYTJNPVGSBZ-YXSASFKJSA-N 1-[4-[6-amino-5-[(Z)-methoxyiminomethyl]pyrimidin-4-yl]oxy-2-chlorophenyl]-3-ethylurea Chemical compound CCNC(=O)Nc1ccc(Oc2ncnc(N)c2\C=N/OC)cc1Cl BJHCYTJNPVGSBZ-YXSASFKJSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N 2-Amino-2-Deoxy-Hexose Chemical compound NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- ZEOWTGPWHLSLOG-UHFFFAOYSA-N Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F Chemical compound Cc1ccc(cc1-c1ccc2c(n[nH]c2c1)-c1cnn(c1)C1CC1)C(=O)Nc1cccc(c1)C(F)(F)F ZEOWTGPWHLSLOG-UHFFFAOYSA-N 0.000 description 1
- 241001264174 Cordyceps militaris Species 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102100023593 Fibroblast growth factor receptor 1 Human genes 0.000 description 1
- 101710182386 Fibroblast growth factor receptor 1 Proteins 0.000 description 1
- 102100023600 Fibroblast growth factor receptor 2 Human genes 0.000 description 1
- 101710182389 Fibroblast growth factor receptor 2 Proteins 0.000 description 1
- 102100027842 Fibroblast growth factor receptor 3 Human genes 0.000 description 1
- 101710182396 Fibroblast growth factor receptor 3 Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 239000009122 Saeng-Ji-Hwang Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- IPZJQDSFZGZEOY-UHFFFAOYSA-N dimethylmethylene Chemical group C[C]C IPZJQDSFZGZEOY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 229910052571 earthenware Inorganic materials 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000013077 scoring method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/30—Other Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Food Science & Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
본 발명은 녹용 추출물 제조방법 및 상기 제조방법으로 제조된 녹용 추출물을 포함하는 녹용경옥고에 관한 것이다.
본 발명의 방법에 의해 제조된 녹용 추출물은 녹용에 포함된 유용한 유효성분인 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량이 높고, 항산화 활성이 우수하므로 인체의 면역력을 높이는 효과를 가진다.
또한 본 발명의 방법으로 제조된 녹용 추출물을 포함하는 녹용경옥고는 전통적인 경옥고의 우수한 효능을 그대로 유지하면서도 부드러운 식감을 가지고, 섭취 후 장에 대한 부담감 및 녹용이 가지는 특이취가 없어 종래 복용을 기피하던 소비자들도 용이하게 복용할 수 있다.The present invention relates to a method for preparing an antler extract and an antler jadeite extract containing the antler extract prepared by the above method.
The antler extract prepared by the method of the present invention has a high content of uronic acid, sulfated-GAGs and sialic acid, which are useful active ingredients contained in antler, It has excellent antioxidant activity, so it has the effect of increasing the immunity of the human body.
In addition, the deer antler extract containing the deer antler extract prepared by the method of the present invention has a soft texture while maintaining the excellent efficacy of the traditional jadeite deer, and there is no burden on the intestines after intake and no specific odor of deer antler, so consumers who have conventionally avoided taking it They can also be taken easily.
Description
본 발명은 녹용 추출물 제조방법 및 상기 제조방법으로 제조된 녹용 추출물을 유효성분으로 포함하는 녹용경옥고에 관한 것이다.The present invention relates to a method for preparing an antler extract and an antler jadeite extract containing the antler extract prepared by the method as an active ingredient.
본 발명의 방법에 의해 제조된 녹용 추출물은 녹용에 포함된 유용한 유효성분인 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량이 높고, 항산화 활성이 우수하므로 인체의 면역력을 높이는 효과를 가진다.The antler extract prepared by the method of the present invention has a high content of uronic acid, sulfated-GAGs and sialic acid, which are useful active ingredients contained in antler, It has excellent antioxidant activity, so it has the effect of increasing the immunity of the human body.
또한 본 발명의 방법으로 제조된 녹용 추출물을 포함하는 녹용경옥고는 전통적인 경옥고의 우수한 효능을 그대로 유지하면서도 부드러운 식감을 가지고, 섭취 후 장에 대한 부담감 및 녹용이 가지는 특이취가 없어 종래 복용을 기피하던 소비자들도 용이하게 복용할 수 있다.In addition, the deer antler extract containing the deer antler extract prepared by the method of the present invention has a soft texture while maintaining the excellent efficacy of the traditional jadeite deer, and there is no burden on the intestines after intake and no specific odor of deer antler, so consumers who have conventionally avoided taking it They can also be taken easily.
녹용(Cervi Parvum Corun, Antler)은 자라기 시작한지 2개월 이내의 골질화 되지 않아 조직이 연하고 털이 골고루 덮여 있는 수컷 사슴의 뿔을 지칭한다. 또한, 뿔 속에 혈액순환이 차단되어 뿔이 단단하게 각질화된 것은 녹각이라고 지칭하며 녹용 대비 효능이 떨어지는 것으로 알려져 있다. 또한 이들의 채취시기를 도과하여 칼슘화된 후 단단해져서 저절로 떨어진 것을 낙각이라고 한다.Antler (Cervi Parvum Corun, Antler) refers to the antlers of male deer that have not been ossified within 2 months of growing and have soft tissue and are evenly covered with hair. In addition, blood circulation in the horn is blocked and the horn is hardened, called antlers, and is known to be less effective than antler. In addition, after they have been calcified by passing the collection period, they become hard and fall off by themselves, which is called fallen leaves.
녹용은 성질이 따듯하고 맛이 달면서 시고, 동의보감 등의 문헌에 의하면 강장작용, 보혈작용, 강정작용, 진통작용, 조혈작용, 생장발육 촉진작용, 심부전증 치료작용 및 기능항진작용 등이 있는 것으로 기록되어 있으며, 이 밖에도 피로회복, 신체 활력 증강 및 신장의 이뇨기능 강화 효과 등 많은 효능을 갖고 있어 예로부터 민간요법을 통하여 널리 이용되어 왔다.Deer antler is warm in nature, sweet in taste and sour, and according to literatures such as Donguibogam, it is recorded that it has tonic, blood-replenishing, strengthening, analgesic, hematopoietic, growth-promoting, heart failure treatment and functional enhancement actions. In addition, it has many efficacies such as fatigue recovery, physical vitality enhancement, and kidney diuretic function enhancement effect, so it has been widely used through folk remedies since ancient times.
녹용은 각종 미네랄 성분, 유리 아미노산, VEGFR-2, FGF-2, VEGF, FGFR1, FGFR2, FGFR3 등과 같은 단백질 성분, 프로스타글란딘류 등과 같은 지질성분을 비롯하여 시알산, 헥소스, 펜토스, 헥소사민, 우론산, 황산화 글리코사미노글리칸, 강글리오사이드 등을 포함하고 있는 것으로 알려져 있으며, 이 중에서도 우론산, 황산화 글리코사미노글리칸 및 시알산은 녹용 추출물의 대표적인 기능성 물질 및 지표 물질로 알려져 있다.Deer antler contains various minerals, free amino acids, protein components such as VEGFR-2, FGF-2, VEGF, FGFR1, FGFR2, FGFR3, etc., lipid components such as prostaglandins, sialic acid, hexose, pentose, hexosamine, It is known to contain uronic acid, sulfated glycosaminoglycan, ganglioside, etc. Among them, uronic acid, sulfated glycosaminoglycan, and sialic acid are known as representative functional substances and indicator substances of deer antler extracts.
한편, 종래의 녹용을 복용하는 경우, 녹용 및 일반 한약재를 혼합한 후 물을 용매로 가열하여 추출하는 방법을 사용하거나, 녹용 및 일반 한약재를 혼합한 후 분쇄하여 가루 형태로 만들고 환으로 복용하는 방법을 주로 이용하였다. 그러나 상기 방법들은 녹용을 다른 한약재와 혼합하여 추출할 경우 녹용에 포함된 유효성분들이 충분히 추출되기 어렵고, 가루 형태를 복용하는 경우 체내에서 유효성분의 완전한 흡수가 어렵다거나 복용시 식감이 좋지 않다는 문제점이 있다.On the other hand, in the case of taking conventional antler, a method of extracting by heating water as a solvent after mixing antler and general herbal medicine, or mixing antler and general herbal medicine and then pulverizing to form a powder and taking it as a pill was mainly used. However, the above methods have problems in that when extracting an antler by mixing it with other herbal medicines, it is difficult to sufficiently extract the active ingredients contained in the antler, and when taking a powder form, it is difficult to completely absorb the active ingredient in the body or the texture is not good when taken. have.
녹용의 유효성분을 효율적으로 추출하기 위한 방법으로서, 한국공개특허공보 제10-2005-0090041호에는 녹용 또는 녹각의 유효성분을 고수율로 추출하기 위해 온수 추출, 단백질 가수분해효소를 이용한 추출 및 염산분해 추출법에 의하여 순차적으로 적용하는 추출물 제조방법에 대해 개시되어 있다. 그러나 상기 방법은 강산의 사용으로 인체에 유용한 유효성분이 파괴되는 것을 피할 수 없다는 문제점이 있다. 또한 한국등록특허공보 제10-39887호는 녹용 발효에 활성을 갖는 코디셉스 밀리타리스(Cordyceps militaris) KCTC 11455BP 및 상기 균주를 이용한 녹용 발효추출물의 제조방법에 관한 것으로, 시알산을 높은 함량으로 함유되는 녹용 발효추출물의 제조가 가능하다는 내용이 개시되어 있다. 그러나, 상기 기술들은 유효성분의 함량을 높이기 위한 구체적인 기술은 제시하지 못하고 있다.As a method for efficiently extracting the active ingredient of antler, Korean Patent Laid-open Publication No. 10-2005-0090041 discloses hot water extraction, extraction using proteolytic enzyme, and hydrochloric acid to extract the active ingredient of antler or antler in high yield. A method for preparing an extract sequentially applied by a decomposition extraction method is disclosed. However, this method has a problem in that it cannot avoid the destruction of active ingredients useful for the human body due to the use of strong acids. In addition, Korean Patent Registration No. 10-39887 relates to Cordyceps militaris KCTC 11455BP having activity in fermentation of deer antler and a method for producing a fermented extract of deer antler using the strain, which contains a high content of sialic acid It is disclosed that it is possible to manufacture a fermented deer antler extract. However, the above techniques do not suggest specific techniques for increasing the content of active ingredients.
따라서, 종래 기술이 가지던 문제점을 개선하면서 녹용에 포함되어 있는 유효성분을 효율적이고 고함량으로 추출하기 위한 최적의 녹용 추출물 제조방법이 필요한 실정이다.Therefore, there is a need for an optimal method for preparing an antler extract for efficiently extracting active ingredients contained in antler in a high content while improving the problems of the prior art.
본 발명자들은 상기 종래 기술의 문제점을 인지하고, 종래의 녹용 추출물 제조방법 대비 인체에 유용한 유효성분의 함량이 높은 녹용 추출물 제조방법을 개발하고자 노력하였다. 그 결과, 특정 단계를 순서대로 포함하는 제조방법을 사용하여 녹용 추출물을 제조할 경우, 녹용에 포함되어 있는 유효성분인 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량이 모두 증진되고, 항산화 활성이 우수한 녹용 추출물을 제조할 수 있다는 점을 입증하고 본 발명을 완성하기에 이르렀다.Recognizing the problems of the prior art, the inventors of the present invention tried to develop a method for preparing an antler extract having a higher content of active ingredients useful for the human body compared to the conventional method for preparing an antler extract. As a result, when the antler extract is prepared using a manufacturing method including specific steps in order, uronic acid, sulfated-GAGs, which are active ingredients contained in the antler, The present invention was completed by proving that an antler extract having an increased content of sialic acid and excellent antioxidant activity could be prepared.
본 발명은 a) 분쇄된 녹용 3 내지 4 kg에 80 %(v/v) 주정 16 내지 18 L를 가한 후, 60 내지 80℃에서 8시간 동안 추출하는 단계; b) 상기 a) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계; c) 상기 b) 단계에서 분리된 잔사물에 정제수 16 내지 18 L를 가한 후, 초음파 추출기를 이용하여 60 내지 80℃에서 8시간 동안 추출하는 단계; d) 상기 c) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계; e) 상기 d) 단계에서 분리된 잔사물에 정제수 16 내지 18 L를 가한 후, 120 내지 140℃에서 8시간 동안 추출하는 단계; f) 상기 e) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계; 및 g) 상기 b), d) 및 f) 단계에서 분리된 여과액을 혼합하는 단계;를 포함하는 녹용 추출물 제조방법에 관한 것이다.The present invention comprises the steps of a) adding 16 to 18 L of 80% (v/v) alcohol to 3 to 4 kg of pulverized antler, and then extracting at 60 to 80 ° C. for 8 hours; b) separating the filtrate and the residue by filtering the extract obtained in step a); c) adding 16 to 18 L of purified water to the residue separated in step b) and extracting at 60 to 80 ° C. for 8 hours using an ultrasonic extractor; d) separating the filtrate and the residue by filtering the extract obtained in step c); e) adding 16 to 18 L of purified water to the residue separated in step d), followed by extraction at 120 to 140° C. for 8 hours; f) filtering the extract obtained in step e) to separate a filtrate and a residue; and g) mixing the filtrate separated in steps b), d) and f).
또한 본 발명은 상기 제조방법에 의해 제조된 녹용 추출물을 포함하는 녹용경옥고에 관한 것이다.In addition, the present invention relates to antler jadeite containing the antler extract prepared by the above production method.
이하 이를 구체적으로 설명한다. 본 발명에서 개시된 다양한 요소들의 모든 조합은 본 발명의 범주에 속한다. 또한, 하기의 구체적인 서술에 의해 본 발명 범주가 제한된다고 볼 수 없다.Hereinafter, this will be described in detail. All combinations of the various elements disclosed herein fall within the scope of the present invention. In addition, it cannot be seen that the scope of the present invention is limited by the specific description below.
본 발명은 하기 단계를 포함하는 녹용 추출물 제조방법을 제공한다:The present invention provides a method for preparing an antler extract comprising the following steps:
a) 분쇄된 녹용 3 내지 4 kg에 80 %(v/v) 주정 16 내지 18 L를 가한 후, 60 내지 80℃에서 8시간 동안 추출하는 단계;a) adding 16 to 18 L of 80% (v/v) alcohol to 3 to 4 kg of pulverized antler, and then extracting at 60 to 80° C. for 8 hours;
b) 상기 a) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계;b) separating the filtrate and the residue by filtering the extract obtained in step a);
c) 상기 b) 단계에서 분리된 잔사물에 정제수 16 내지 18 L를 가한 후, 초음파 추출기를 이용하여 60 내지 80℃에서 8시간 동안 추출하는 단계;c) adding 16 to 18 L of purified water to the residue separated in step b) and extracting at 60 to 80 ° C. for 8 hours using an ultrasonic extractor;
d) 상기 c) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계;d) separating the filtrate and the residue by filtering the extract obtained in step c);
e) 상기 d) 단계에서 분리된 잔사물에 정제수 16 내지 18 L를 가한 후, 120 내지 140℃에서 8시간 동안 추출하는 단계;e) adding 16 to 18 L of purified water to the residue separated in step d), followed by extraction at 120 to 140° C. for 8 hours;
f) 상기 e) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계; 및f) filtering the extract obtained in step e) to separate a filtrate and a residue; and
g) 상기 b), d) 및 f) 단계에서 분리된 여과액을 혼합하는 단계.g) mixing the filtrate separated in steps b), d) and f).
본 발명에서 "녹용"은 한약재의 일종으로 자라기 시작한지 2개월 이내의 골질화되지 않아 조직이 연하고 털이 골고루 덮여 있는 수컷 사슴의 뿔을 의미한다. 상기 녹용은 팁, 분골, 상대, 중대 및 하대로 분류되며, 순서대로 뿔의 위쪽부터 뿌리(사슴머리) 부분으로 내려가는 부위를 지칭한다.In the present invention, "deer antler" refers to antlers of male deer that are not ossified within 2 months of starting to grow as a kind of herbal medicine and have soft tissue and are evenly covered with hair. The antler is classified into tip, bone, upper, middle, and lower parts, and refers to the part descending from the upper part of the horn to the root (deer head) part in order.
본 발명에서 녹용의 원산지는 러시아산, 뉴질랜드산, 중국산 또는 국내산일 수 있으나, 본 발명의 실시예들에 따르면, 러시아산이 바람직할 수 있다.In the present invention, the country of origin of the antler may be Russian, New Zealand, Chinese, or domestic, but according to embodiments of the present invention, Russian may be preferable.
본 발명에서 원재료로서 녹용은 팁, 분골, 상대, 중대 및 하대에서 선택된 어느 하나 이상일 수 있으나, 녹용의 상대를 사용하는 것이 바람직하며, 원재료로 녹용의 상대가 아닌 다른 부위를 사용하는 경우, 원재료 자체에 포함되어 있는 유효성분 자체의 양이 적어 본 발명에서 의도하는 유효성분이 증진된 녹용 추출물을 수득하지 못할 수 있다.In the present invention, the antler as a raw material may be any one or more selected from tip, bone, upper, middle, and lower legs, but it is preferable to use the counterpart of the antler, and when a part other than the counterpart of the antler is used as the raw material, the raw material itself Since the amount of the active ingredient itself contained in is small, it may not be possible to obtain an antler extract with enhanced active ingredients intended in the present invention.
본 발명의 a) 단계에서 "주정"은 전분이 함유된 물료 또는 당분이 함유된 물료를 발효시켜 알코올분 85℃ 이상으로 증류한 것을 의미한다. 본 발명에서 주정은 발효주정이 바람직하며, 녹용에 포함된 유효성분을 최대한 추출하기 위해 농도가 70 내지 80 %(v/v)인 것이 바람직하다. 본 발명의 실시예들에 따르면, 추출용매로서 주정은 80 %(v/v)의 농도를 가지는 것이 바람직하나 이에 제한되지 않는다.In the step a) of the present invention, "alcohol" means that a starch-containing material or a sugar-containing material is fermented and distilled to an alcohol content of 85 ° C or higher. In the present invention, the alcohol is preferably fermented alcohol, and the concentration is preferably 70 to 80% (v / v) in order to maximize the extraction of the active ingredient contained in the antler. According to embodiments of the present invention, alcohol as an extraction solvent preferably has a concentration of 80% (v / v), but is not limited thereto.
본 발명의 c) 단계에서는 초음파 추출기를 사용한 초음파 추출을 적용한다. 초음파 추출은 기포에 의한 용매의 침투성을 향상시키고 추출온도를 저하시킬 수 있어 천연 추출물의 원재료에서 열에 불안정한 물질의 파괴를 막으면서 추출수율을 증대시킬 수 있다.In step c) of the present invention, ultrasonic extraction using an ultrasonic extractor is applied. Ultrasonic extraction can improve the permeability of the solvent by bubbles and lower the extraction temperature, thereby increasing the extraction yield while preventing the destruction of heat-labile substances in the raw material of the natural extract.
본 발명에서 a) 및 c) 단계는 60 내지 80℃의 온도에서 수행하는 것일 수 있으며, 바람직하게는 65 내지 75℃의 온도에서 수행하는 것일 수 있다. 상기 범위를 초과하는 온도로 열을 가하는 경우, 추출 수율이 증가하거나 추출공정 시간이 단축될 수 있으나, 녹용과 같은 천연물 원재료는 원재료 내에 포함된 유효성분이 열에 의해 변성될 수 있다는 중요한 문제점이 있다. 또한 상기 범위 미만의 온도로 열을 가하는 경우 추출효율 측면에서 바람직하지 않을 수 있다. 따라서, a) 및 c) 단계에 있어서 상기 범위의 온도에서 수행하는 것은 a) 및 c) 단계에서 추출되는 유효성분의 온전성 및 추출수율 측면에서 매우 유리하다. 본 발명의 실시예들에 따르면, a) 및 c) 단계는 70℃의 온도에서 수행될 수 있으나 이에 제한되지 않는다.In the present invention, steps a) and c) may be performed at a temperature of 60 to 80 °C, preferably at a temperature of 65 to 75 °C. When heat is applied at a temperature exceeding the above range, the extraction yield may increase or the extraction process time may be shortened. In addition, when heat is applied at a temperature below the above range, it may not be preferable in terms of extraction efficiency. Therefore, performing steps a) and c) at a temperature within the above range is very advantageous in terms of integrity and extraction yield of the active ingredient extracted in steps a) and c). According to embodiments of the present invention, steps a) and c) may be performed at a temperature of 70° C., but are not limited thereto.
본 발명에서 e) 단계는 120 내지 140℃ 온도에서 수행될 수 있다. 상기 범위를 초과하는 온도에서 수행되는 경우, 가해진 에너지 대비 추출효율 측면에서 바람직하지 않을 수 있으며, 상기 범위 미만의 온도에서 수행되는 경우, e) 단계를 통해 추출하려는 유효성분이 충분히 추출되지 않을 수 있다. 본 발명의 실시예들에 따르면, e) 단계는 130℃에서 수행되는 것이 바람직할 수 있으나 이에 제한되지 않는다.In the present invention, step e) may be performed at a temperature of 120 to 140 °C. When performed at a temperature exceeding the above range, it may not be preferable in terms of extraction efficiency compared to the applied energy, and when performed at a temperature below the above range, the active ingredient to be extracted through step e) may not be sufficiently extracted. According to embodiments of the present invention, step e) may be preferably performed at 130° C., but is not limited thereto.
본 발명에서 상기 a)와 b) 단계 사이, 상기 c)와 d) 단계 사이 및 상기 e)와 f) 단계 사이에 각각 4℃의 온도에서 숙성시키는 단계를 더 포함할 수 있다. 상기 숙성단계는 녹용 내 유효성분의 추출율을 증가시키며, 숙성단계를 포함하지 않는 경우 유효성분의 함량 및 항산화 활성이 본 발명에서 의도하는 정도에 이르지 못할 수 있다.In the present invention, aging at a temperature of 4° C. may be further included between steps a) and b), between steps c) and d), and between steps e) and f). The aging step increases the extraction rate of the active ingredient in the deer antler, and if the aging step is not included, the content and antioxidant activity of the active ingredient may not reach the level intended in the present invention.
본 발명에서 a) 내지 g)의 알파벳 순서대로 나열된 제조방법은 각각의 단계가 알파벳 순서대로 순차적으로 수행되는 것이 특히 중요하다. 각각의 단계의 순서가 변경되는 경우, 최종적으로 수득된 녹용 추출물에 포함된 유효성분이 본 발명이 의도하고 있는 수준으로 추출되지 않을 수 있다. 후술하는 실험예에 따르면, 제조방법의 단계의 순서가 변경되는 경우 본 발명 제조방법의 단계의 순서에 따른 녹용 추출물 대비 우론산, 황산화 글리코사미노글리칸, 시알산의 함량이 본래의 단계대로 수행된 경우 대비 낮은 함량으로 추출되었으며, 항산화 활성 역시 낮아짐 확인하였다.In the present invention, it is particularly important that each step of the manufacturing methods listed in alphabetical order from a) to g) is sequentially performed in alphabetical order. If the order of each step is changed, the active ingredients contained in the finally obtained antler extract may not be extracted to the level intended by the present invention. According to an experimental example to be described later, when the order of the steps of the manufacturing method is changed, the content of uronic acid, sulfated glycosaminoglycan, and sialic acid compared to the antler extract according to the order of steps of the manufacturing method of the present invention remains the original step. It was extracted with a lower content compared to the case where it was performed, and it was confirmed that the antioxidant activity was also lowered.
본 발명의 제조방법은 제조된 녹용 추출물에 포함된 녹용의 생리활성물질인 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량이 모두 증진된 것인 녹용 추출물 제조방법일 수 있다.The production method of the present invention increases the contents of uronic acid, sulfated-GAGs, and sialic acid, which are physiologically active substances of antler, contained in the prepared antler extract. It may be a method for preparing an antler extract.
본 발명에서 "우론산(uronic acid)"은 알데하이드기와 카복실기를 동시에 지닌 당의 유도체를 의미하며, 녹용 추출물의 기능성 물질 또는 지표 물질로 알려져 있으며, 인체에서 세포 형태를 유지하고, 외부의 손상이나 세균 감염에 대해 방어하는 등 생리학적, 면역학적 역할을 하는 것으로 알려져 있다.In the present invention, "uronic acid" refers to a sugar derivative having both an aldehyde group and a carboxyl group, and is known as a functional substance or indicator substance of antler extract, maintains cell shape in the human body, external damage or bacterial infection It is known to play physiological and immunological roles, such as defending against
본 발명에서 "글리코사미노글리칸(glycosaminoglycans, GAGs)"은 아미노헥소스 단위를 포함하는 올리고당류 또는 다당류를 의미한다. 황산화 글리코사미노글리칸(Sulfated-GAG, S-GAG)은 관절의 연골과 디스크의 수핵 등의 주 성분으로서 녹용 추출물의 기능성 물질 또는 지표 물질로 알려져 있으며, 세포재생 효과, 관절염 치료 효과, 항염 효과, 및 수분 유지 효과 등이 보고된 바 있다.In the present invention, "glycosaminoglycans (GAGs)" means oligosaccharides or polysaccharides containing aminohexose units. Sulfated glycosaminoglycan (Sulfated-GAG, S-GAG) is the main component of joint cartilage and disc nucleus pulposus, and is known as a functional substance or indicator substance of antler extract, and has cell regeneration effect, arthritis treatment effect, anti-inflammatory effect, and water retention effect have been reported.
본 발명에서 "시알산(sialic acid)"은 뉴라민산(neuraminic acid)의 아실 유도체의 총칭으로 현재 동물계에 20여 종 이상이 알려져 있으며, 바이러스에 대한 리셉터 작용, 독소의 중화, 세포와 분자의 면역학적 인식 부위, 세포접착 또는 암의 전이 등 중요한 생리기능에 관여하고 있는 산성당으로 보고되어 있다.In the present invention, "sialic acid" is a generic term for acyl derivatives of neuraminic acid, and more than 20 species are currently known in the animal world. It has been reported as an acidic sugar involved in important physiological functions such as immunological recognition sites, cell adhesion or cancer metastasis.
상기 녹용에 포함된 유효성분인 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량의 증가는 녹용 추출물의 생리적 효능의 증가와 연관되고, 따라서 본 발명에 따른 제조방법에 의해 제조된, 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량이 모두 증진된 녹용 추출물은 건강기능식품 조성물, 약학 조성물 또는 화장품 조성물의 유효성분으로 활용될 수 있다.An increase in the content of uronic acid, sulfated-GAGs, and sialic acid, which are active ingredients contained in the antler, is associated with an increase in the physiological efficacy of the antler extract, Therefore, the deer antler extract with increased contents of uronic acid, sulfated-GAGs, and sialic acid, prepared by the manufacturing method according to the present invention, is a health functional food. It can be used as an active ingredient of a composition, pharmaceutical composition or cosmetic composition.
본 발명의 다른 일 양태에 따르면, 본 발명에 녹용 추출물 제조방법에 의해 제조된 녹용 추출물을 포함하는 녹용경옥고를 제공한다.According to another aspect of the present invention, an antler jadeite containing an antler extract prepared by the method for preparing an antler extract is provided.
본 발명에서 “경옥고”는 동의보감에 보혈 강장 및 허약 체질 개선제로 기재되어 있는, 인삼, 복령, 생지황 즙 및 꿀의 약재를 주요 성분으로 포함하는 한약재를 의미한다. 상기 경옥고는 여러 약리활성이 알려져 있는데, 동의보감과 방약합편에는 백발이 검어지고 빠진 이가 다시 날 정도로 여러 가지 병과 체력약화를 회복시키는 효과가 있는 것으로 기록되어 있으며, 이러한 고문헌적 자료 외에도 현대에 이르러서는 경옥고 수침엑스가 항염증, 위궤양억제, 진통효과 및 정상체온유지에 효과가 있으며, 혈당강하, 혈청중의 총 콜레스테롤 및 총 트리글리세라이드 수치의 감소, 혈압강하효과, 지구력 및 체중감소에 있어서도 용량 의존적으로 효과가 있음이 보고되어 있다.In the present invention, "Gyeongokgo" refers to herbal medicines containing medicinal herbs of ginseng, bokryeong, Saengjihwang juice and honey, which are described in Donguibogam as a tonic for blood and a weak constitution improver, as main ingredients. The jadeitego is known for its various pharmacological activities, and it is recorded that it has the effect of restoring various diseases and physical weakness to the extent that gray hair blackens and missing teeth grow again in Donguibogam and Herbal Medicine Combination. Souchim extract is effective in anti-inflammation, suppression of gastric ulcer, analgesic effect and maintenance of normal body temperature, and is also effective in a dose-dependent manner in lowering blood sugar, reducing total cholesterol and total triglyceride levels in serum, lowering blood pressure, endurance and weight loss. It has been reported that there is
본 발명에 있어서 “녹용경옥고”는 상기 경옥고에 녹용 추출물을 주요 성분으로 더 포함하는 경옥고를 의미한다.In the present invention, “deer antler jadeite go” means jadeite go further comprising an antler extract as a main component in the jadeite go.
본 발명에서 녹용경옥고는 다양한 제형을 가질 수 있으며, 예를 들면, 수분 함량 또는 점성에 따라 액상 상태, 반고형 상태 또는 고형 상태의 제형을 가질 수 있다. 또한, 본 발명의 녹용경옥고는 형상, 가공 방법, 포장 방법 등에 따라 스틱 파우치, 환 또는 정제 형태로 제형화될 수 있다.In the present invention, the deer antler jadeite may have various formulations, for example, it may have a formulation in a liquid state, semi-solid state or solid state depending on the moisture content or viscosity. In addition, the deer antler jadeite of the present invention may be formulated in the form of a stick pouch, pill or tablet depending on the shape, processing method, packaging method, and the like.
본 발명의 녹용 추출물 제조방법에 따르면 종래 녹용 추출법 대비 유효성분의 온전성을 유지하면서도 높은 함량으로 포함하는 녹용 추출물을 제조할 수 있다.According to the method for preparing the antler extract of the present invention, it is possible to prepare an antler extract containing a high content while maintaining the integrity of the active ingredient compared to the conventional antler extraction method.
본 발명의 방법에 의해 제조된 녹용 추출물은 녹용에 포함된 유용한 유효성분인 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량이 높고, 항산화 활성이 우수하므로 인체의 면역력을 높이는 효과를 가진다.The antler extract prepared by the method of the present invention has a high content of uronic acid, sulfated-GAGs and sialic acid, which are useful active ingredients contained in antler, It has excellent antioxidant activity, so it has the effect of increasing the immunity of the human body.
또한 본 발명의 방법으로 제조된 녹용 추출물을 포함하는 녹용경옥고는 전통적인 경옥고의 우수한 효능을 그대로 유지하면서도 부드러운 식감을 가지고, 섭취 후 장에 대한 부담감 및 녹용이 가지는 특이취가 없어 종래 복용을 기피하던 소비자들도 용이하게 복용할 수 있다.In addition, the deer antler extract containing the deer antler extract prepared by the method of the present invention has a soft texture while maintaining the excellent efficacy of the traditional jadeite deer, and there is no burden on the intestines after intake and no specific odor of deer antler, so consumers who have conventionally avoided taking it They can also be taken easily.
이하 본 발명을 실시예에 의해 보다 상세하게 설명한다. 그러나 이들 실시예는 본 발명을 예시적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것은 아니다. 또한, 본 명세서에서 특별히 정의되지 않은 용어들에 대해서는 본 발명이 속하는 기술 분야에서 통상적으로 사용되는 의미를 갖는 것으로 이해되어야 할 것이다.Hereinafter, the present invention will be described in more detail by examples. However, these examples are intended to illustrate the present invention by way of example, and the scope of the present invention is not limited by these examples. In addition, terms not specifically defined in this specification should be understood to have meanings commonly used in the technical field to which the present invention belongs.
1. 녹용 추출물의 유효성분 함량 및 항산화 활성 확인1. Confirmation of Active Ingredient Content and Antioxidant Activity of Deer Antler Extract
(1) 실시예 및 비교예의 제조(1) Preparation of Examples and Comparative Examples
1) 실시예 11) Example 1
분쇄된 녹용(러시아산, 상대) 3.5 kg에 80 %(v/v) 주정 17 L를 가한 후, 70℃에서 8시간 동안 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(1차 추출).After adding 17 L of 80% (v/v) alcohol to 3.5 kg of crushed antler (Russian, Daesang), extracting at 70℃ for 8 hours, cooling the obtained extract to 4℃ and aging for 16 hours , The aged extract was filtered to separate the filtrate and residue (primary extraction).
상기 1차 추출에서 분리된 잔사물에 정제수 17 L를 가한 후, 초음파 추출기(Ilshin Lab, 750 W/cm2)를 이용하여 70℃에서 지속적으로 교반하면서 8시간 동안 초음파 처리하여 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(2차 추출).After adding 17 L of purified water to the residue separated in the primary extraction, using an ultrasonic extractor (Ilshin Lab, 750 W/cm 2 ), ultrasonication was performed for 8 hours while continuously stirring at 70° C. for extraction, and then the obtained After the extract was cooled to 4° C. and aged for 16 hours, the aged extract was filtered to separate the filtrate and residue (secondary extraction).
상기 2차 추출에서 분리된 잔사물에 정제수 17 L를 가한 후, 130℃에서 8시간 동안 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(3차 추출).After adding 17 L of purified water to the residue separated in the secondary extraction, extraction was performed at 130 ° C for 8 hours, the obtained extract was cooled to 4 ° C and aged for 16 hours, and then the aged extract was filtered and filtered Liquor and residue were separated (third extraction).
이후 상기 1차 내지 3차 추출에서 수득된 여과액을 혼합하고 감압농축 후 동결건조하였으며, 이를 실시예 1의 시료로 하였다.Thereafter, the filtrate obtained in the first to third extractions was mixed, concentrated under reduced pressure, and lyophilized, and this was used as the sample of Example 1.
2) 비교예 12) Comparative Example 1
분쇄된 녹용(러시아산, 상대) 3.5 kg에 80 %(v/v) 주정 17 L를 가한 후, 70℃에서 24시간 동안 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하고, 분리된 여과액을 감압농축 후 동결건조하였으며, 이를 비교예 1의 시료로 하였다.After adding 17 L of 80% (v/v) alcohol to 3.5 kg of crushed antler (Russian, Daesang), extracting at 70℃ for 24 hours, cooling the obtained extract to 4℃ and aging for 16 hours , The aged extract was filtered to separate the filtrate and residue, and the separated filtrate was concentrated under reduced pressure and lyophilized, which was used as the sample of Comparative Example 1.
3) 비교예 23) Comparative Example 2
분쇄된 녹용(러시아산, 상대) 3.5 kg에 80 %(v/v) 정제수 17 L를 가한 후, 초음파 추출기를 이용하여 70℃에서 24시간 동안 지속적으로 교반하면서 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하고, 분리된 여과액을 감압농축 후 동결건조하였으며, 이를 비교예 2의 시료로 하였다.After adding 17 L of 80% (v/v) purified water to 3.5 kg of pulverized antler (Russian, Daesang), extracting with continuous stirring at 70 ° C for 24 hours using an ultrasonic extractor, and then the obtained extract was heated to 4 ° C After cooling and aging for 16 hours, the aged extract was filtered to separate a filtrate and a residue, and the separated filtrate was concentrated under reduced pressure and freeze-dried, which was used as a sample of Comparative Example 2.
4) 비교예 34) Comparative Example 3
분쇄된 녹용(러시아산, 상대) 3.5 kg에 80 %(v/v) 정제수 17 L를 가한 후, 130℃에서 24시간 동안 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하고, 분리된 여과액을 감압농축 후 동결건조하였으며, 이를 비교예 3의 시료로 하였다.After adding 17 L of 80% (v/v) purified water to 3.5 kg of crushed antler (Russian, Daesang), extracting at 130℃ for 24 hours, cooling the obtained extract to 4℃ and aging for 16 hours , The aged extract was filtered to separate the filtrate and the residue, and the separated filtrate was concentrated under reduced pressure and lyophilized, which was used as the sample of Comparative Example 3.
5) 비교예 45) Comparative Example 4
분쇄된 녹용(러시아산, 상대) 3.5 kg에 80 %(v/v) 주정 17 L를 가한 후, 70℃에서 12시간 동안 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(1차 추출).After adding 17 L of 80% (v/v) alcohol to 3.5 kg of crushed antler (Russian, Daesang), extracting at 70℃ for 12 hours, cooling the obtained extract to 4℃ and aging for 16 hours , The aged extract was filtered to separate the filtrate and residue (primary extraction).
상기 1차 추출에서 분리된 잔사물에 정제수 17 L를 가한 후, 초음파 추출기를 이용하여 70℃에서 12시간 동안 지속적으로 교반하면서 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(2차 추출).After adding 17 L of purified water to the residue separated in the first extraction, extracting with continuous stirring at 70 ° C for 12 hours using an ultrasonic extractor, cooling the obtained extract to 4 ° C and aging for 16 hours , The aged extract was filtered to separate the filtrate and residue (secondary extraction).
이후 상기 1차 및 2차 추출에서 수득된 여과액을 혼합한 후, 분리된 여과액을 감압농축 후 동결건조하였으며, 이를 비교예 4의 시료로 하였다.After mixing the filtrate obtained in the first and second extractions, the separated filtrate was concentrated under reduced pressure and freeze-dried, which was used as the sample of Comparative Example 4.
6) 비교예 56) Comparative Example 5
분쇄된 녹용(러시아산, 상대) 3.5 kg에 정제수 17 L를 가한 후, 초음파 추출기를 이용하여 70℃에서 12시간 동안 지속적으로 교반하면서 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(1차 추출).After adding 17 L of purified water to 3.5 kg of crushed antler (Russian, Daesang), extracting using an ultrasonic extractor with continuous stirring at 70 ° C for 12 hours, then cooling the obtained extract to 4 ° C and aging for 16 hours After that, the aged extract was filtered to separate the filtrate and residue (primary extraction).
상기 1차 추출에서 분리된 잔사물에 정제수 17 L를 가한 후, 130℃에서 12시간 동안 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(2차 추출).After adding 17 L of purified water to the residue separated in the first extraction, extraction was performed at 130 ° C for 12 hours, the obtained extract was cooled to 4 ° C and aged for 16 hours, and then the aged extract was filtered and filtered Liquor and residue were separated (second extraction).
이후 상기 1차 및 2차 추출에서 수득된 여과액을 혼합하고 감압농축 후 동결건조하였으며, 이를 비교예 5의 시료로 하였다.Thereafter, the filtrates obtained in the first and second extractions were mixed, concentrated under reduced pressure, and lyophilized, and this was used as a sample of Comparative Example 5.
7) 7) 비교예comparative example 6 6
분쇄된 녹용(러시아산, 상대) 3.5 kg에 정제수 17 L를 가한 후, 130℃에서 8시간 동안 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(1차 추출).After adding 17 L of purified water to 3.5 kg of crushed antler (Russian, Daesang), extracting at 130 ° C for 8 hours, cooling the obtained extract to 4 ° C, aging for 16 hours, filtering the aged extract The filtrate and residue were separated (first extraction).
상기 1차 추출에서 분리된 잔사물에 초음파 추출기를 이용하여 70℃에서 8시간 동안 지속적으로 교반하면서 추출한 다음, 수득된 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(2차 추출).The residue separated in the primary extraction was extracted with continuous stirring at 70°C for 8 hours using an ultrasonic extractor, then the obtained extract was cooled to 4°C and aged for 16 hours, and then the aged extract was filtered. to separate the filtrate and residue (secondary extraction).
상기 2차 추출에서 분리된 잔사물에 80 %(v/v) 주정 17 L를 가한 후, 70℃에서 8시간 동안 추출한 다음, 상기 추출물을 4℃로 냉각시키고 16시간 동안 숙성시킨 후, 상기 숙성된 추출물을 여과하여 여과액 및 잔사물을 분리하였다(3차 추출).After adding 17 L of 80% (v/v) alcohol to the residue separated in the secondary extraction, extracting at 70° C. for 8 hours, cooling the extract to 4° C., aging for 16 hours, and then aging The extracted extract was filtered to separate the filtrate and residue (third extraction).
이후 상기 1차 내지 3차 추출에서 수득된 여과액을 혼합하고 감압농축 후 동결건조하였으며, 이를 비교예 6의 시료로 하였다.Thereafter, the filtrate obtained in the first to third extractions was mixed, concentrated under reduced pressure, and lyophilized, and this was used as a sample of Comparative Example 6.
(2) (2) 실험예Experimental example 1. 녹용 추출물의 유효성분의 함량 확인 1. Confirmation of active ingredient content of antler extract
1) One) 우론산uronic acid (( uronicuronic acid) 함량 acid) content
25 mM 사붕산나트륨(sodium tetraborate)을 진한 황산 용액으로 제조하고, 상기 용액 0.2 ml 및 시료 0.05 ml를 96-웰 플레이트에 넣고 잘 섞은 후, 100℃에서 10분 동안 가열 후 상온에서 15분간 냉각하였다. 그 다음 0.125 % 카바졸(carbazole) 0.05 ml를 가하고 100℃에서 10분 가열 후 상온에서 15분간 방냉하였다. 이후 ELISA reader (Asys UVM340, Biochrom, Eugendorf, Austria)를 이용하여 550 nm에서 흡광도를 측정하고, 갈락투론산(galacturonic acid)을 이용하여 작성한 표준곡선으로부터 함량을 계산하였으며, 결과는 하기 표 1에 나타내었다.25 mM sodium tetraborate was prepared as a concentrated sulfuric acid solution, 0.2 ml of the solution and 0.05 ml of the sample were put into a 96-well plate, mixed well, heated at 100 ° C. for 10 minutes, and then cooled at room temperature for 15 minutes. . Then, 0.05 ml of 0.125% carbazole was added, heated at 100° C. for 10 minutes, and then allowed to cool at room temperature for 15 minutes. Then, the absorbance was measured at 550 nm using an ELISA reader (Asys UVM340, Biochrom, Eugendorf, Austria), and the content was calculated from a standard curve prepared using galacturonic acid. The results are shown in Table 1 below. was
상기 표에서 확인할 수 있는 바와 같이, 본 발명의 제조방법을 통해 제조된 녹용 추출물은 제조방법의 단계 중 일부를 제외하고 추출한 비교예 1 내지 5 대비 우론산의 함량이 증가하였으며, 또한 본 발명의 각 단계를 순차적으로 수행하지 않은 비교예 6와 대비해서도 우론산의 함량이 증가하였다. 상기 결과는 본 발명의 제조단계를 모두 포함하며 순차적으로 수행하는 경우에 우론산의 함량이 증가된 녹용 추출물을 수득할 수 있다는 점을 나타낸다.As can be seen from the table above, the antler extract prepared through the manufacturing method of the present invention has an increased content of uronic acid compared to Comparative Examples 1 to 5, which were extracted except for some of the steps of the manufacturing method, and also each of the steps of the present invention The content of uronic acid also increased compared to Comparative Example 6 in which the steps were not performed sequentially. The above results indicate that an antler extract having an increased content of uronic acid can be obtained when all of the manufacturing steps of the present invention are performed sequentially.
2) 2) 황산화oxidization 글리코사미노글리칸glycosaminoglycans (sulfated- (sulfated- GAGsGAGs ) 함량) content
NaCl 1.185 g, 글리신 1.52 g, 1,9-dimethylmemethylene blue 0.008 g, HCl 0.47 mL를 500 ml 증류수에 녹여서 DMB (dimethylmethylene blue) 염료 용액(525 nm에서의 흡광도: 0.34)을 제조하였다. 이후 1 mg/ml의 실시예 및 비교예 시료 0.05 ml 및 상기 제조한 DMB 1 ml를 혼합하고, 525 nm에서 흡광도를 측정하고, 콘드로이틴황산(chondroitin-4-sulfate)을 이용하여 작성한 표준곡선으로부터 함량을 계산하였으며, 결과는 하기 표 2에 나타내었다.1.185 g of NaCl, 1.52 g of glycine, 0.008 g of 1,9-dimethylmemethylene blue, and 0.47 mL of HCl were dissolved in 500 ml of distilled water to prepare a DMB (dimethylmethylene blue) dye solution (absorbance at 525 nm: 0.34). Thereafter, 0.05 ml of 1 mg/ml Example and Comparative Example samples and 1 ml of DMB prepared above were mixed, the absorbance was measured at 525 nm, and the content was measured from the standard curve prepared using chondroitin-4-sulfate. was calculated, and the results are shown in Table 2 below.
상기 표에서 확인할 수 있는 바와 같이, 본 발명의 제조방법을 통해 제조된 녹용 추출물은 제조방법의 단계 중 일부를 제외하고 추출한 비교예 1 내지 5 대비 황산화 글리코사미노글리칸의 함량이 증가하였으며, 또한 본 발명의 각 단계를 순차적으로 수행하지 않은 비교예 6와 대비해서도 황산화 글리코사미노글리칸의 함량이 증가하였다. 상기 결과는 본 발명의 제조단계를 모두 포함하며 순차적으로 수행하는 경우에 황산화 글리코사미노글리칸의 함량이 증가된 녹용 추출물을 수득할 수 있다는 점을 나타낸다.As can be seen from the table above, the antler extract prepared by the manufacturing method of the present invention has an increased content of sulfated glycosaminoglycan compared to Comparative Examples 1 to 5 extracted except for some of the steps of the manufacturing method, Also, compared to Comparative Example 6 in which each step of the present invention was not performed sequentially, the content of sulfated glycosaminoglycan increased. The above results indicate that an antler extract having an increased content of sulfated glycosaminoglycan can be obtained when all of the manufacturing steps of the present invention are performed sequentially.
3) 시알산 (3) sialic acid ( sialicsialic acid) 함량 acid) content
녹용 추출물에 0.1 N H2SO4 용액 1 mL를 가하고 80℃에서 1시간 동안 가수분해하여 시알산을 추출하였다. 그 다음 0.25 M 과옥소산염(sodium periodate) 용액을 첨가하여 4℃에서 45분 동안 반응시키고 0.32 M 티오황산나트륨(sodium thiosulfate) 용액 0.25 ml를 첨가하여 반응을 정지시킨 후, 0.1 M TBA 용액 1.25 ml을 첨가하여 100℃에서 15 분간 발색시키고 상온에서 냉각하였다. 이후 5% 12 N HCl을 포함하는 부탄올(butanol) 용액으로 반응액을 추출하여 549 nm에서 흡광도를 측정하고, N-아세틸뉴라민산(N-acetylneuraminic acid)을 이용하여 작성한 표준곡선으로부터 함량을 계산하였으며, 결과는 하기 표 3에 나타내었다.Sialic acid was extracted by adding 1 mL of 0.1 NH 2 SO 4 solution to the deer antler extract and hydrolyzing at 80° C. for 1 hour. Then, a 0.25 M periodate solution was added to react at 4° C. for 45 minutes, and the reaction was stopped by adding 0.25 ml of a 0.32 M sodium thiosulfate solution, followed by 1.25 ml of a 0.1 M TBA solution. The color was developed at 100° C. for 15 minutes and cooled at room temperature. Thereafter, the reaction solution was extracted with a butanol solution containing 5% 12 N HCl, the absorbance was measured at 549 nm, and the content was calculated from a standard curve prepared using N-acetylneuraminic acid. And the results are shown in Table 3 below.
상기 표에서 확인할 수 있는 바와 같이, 본 발명의 제조방법을 통해 제조된 녹용 추출물은 제조방법의 단계 중 일부를 제외하고 추출한 비교예 1 내지 5 대비 시알산의 함량이 증가하였으며, 또한 본 발명의 각 단계를 순차적으로 수행하지 않은 비교예 6와 대비해서도 시알산의 함량이 증가하였다. 상기 결과는 본 발명의 제조단계를 모두 포함하며 순차적으로 수행하는 경우에 시알산의 함량이 증가된 녹용 추출물을 수득할 수 있다는 점을 나타낸다.As can be seen from the table above, the antler extract prepared through the manufacturing method of the present invention had an increased sialic acid content compared to Comparative Examples 1 to 5, which were extracted except for some of the steps of the manufacturing method. Compared to Comparative Example 6 in which the steps were not sequentially performed, the content of sialic acid also increased. The above results indicate that an antler extract with increased sialic acid content can be obtained when all of the manufacturing steps of the present invention are performed sequentially.
(3) (3) 실험예Experimental example 2. 녹용 추출물의 항산화 활성 확인 2. Confirmation of antioxidant activity of antler extract
본 발명의 제조방법으로 제조된 녹용 추출물의 항산화 활성은 DPPH 라디칼 소거 활성을 통해 확인하였다.Antioxidant activity of the antler extract prepared by the production method of the present invention was confirmed through DPPH radical scavenging activity.
구체적으로 1 mg/ml 농도의 대조군(메탄올), 실시예 및 비교예 시료 60 μl에 DPPH 용액 60 μl을 첨가하고 10초 동안 교반한 다음, 혼합용액을 96-웰 플레이트에 첨가한 후, 약 30분간 방치하였다. 이후 UV 분광광도계(UV spectrophotometer)를 사용하여 517 nm에서 흡광도를 3회 측정 후 평균값을 계산하였다.Specifically, 60 μl of DPPH solution was added to 60 μl of control (methanol), examples and comparative samples at a concentration of 1 mg/ml, stirred for 10 seconds, and then the mixed solution was added to a 96-well plate, followed by about 30 left for a minute. Then, the absorbance was measured three times at 517 nm using a UV spectrophotometer, and the average value was calculated.
DPPH 라디칼 소거 활성 하기 수학식 1에 따라 계산하였으며, 실험결과는 하기 표 4에 나타내었다. DPPH radical scavenging activity was calculated according to Equation 1 below, and the experimental results are shown in Table 4 below.
[수학식 1][Equation 1]
DPPH 라디칼 소거 활성(%) = [(대조군 흡광도 - 샘플 시료의 흡광도)/(대조군 흡광도)] x 100DPPH radical scavenging activity (%) = [(control absorbance - absorbance of sample sample)/(control absorbance)] x 100
상기 표에서 확인할 수 있는 바와 같이, 본 발명의 제조방법을 통해 제조된 녹용 추출물은 제조방법의 단계 중 일부를 제외하고 추출한 비교예 1 내지 5 대비 높은 DPPH 라디칼 소거 활성을 나타냈으며, 본 발명의 각 단계를 순차적으로 수행하지 않은 비교예 6의 녹용 추출물과 대비해서도 DPPH 라디칼 소거 활성이 높았다. 이는 본 발명의 제조단계를 모두 포함하며 순차적으로 수행하는 경우에 항산화 활성이 우수한 녹용 추출물을 수득할 수 있다는 점을 나타낸다.As can be seen from the table above, the antler extract prepared by the manufacturing method of the present invention exhibited higher DPPH radical scavenging activity compared to Comparative Examples 1 to 5 extracted except for some of the steps of the manufacturing method. DPPH radical scavenging activity was also high compared to the antler extract of Comparative Example 6 in which the steps were not sequentially performed. This indicates that an antler extract having excellent antioxidant activity can be obtained when all the manufacturing steps of the present invention are included and performed sequentially.
2. 녹용 추출물을 포함하는 2. Containing antler extract 녹용경옥고의of antler jadeite 제조 및 관능검사 시험 Manufacturing and sensory testing
(1) (One) 실시예Example 및 and 비교예의comparative courtesy 제조 Produce
1) One) 실시예Example 2 2
배합용 용기에 인삼 분말 1.4 kg 및 복령 분말 2.1 kg을 넣고 균일하게 혼합한 다음 생지황 착즙 14.9 kg을 거름망을 통하여 투입하고 분말 덩어리가 없어질 때까지 약 20 내지 30분 동안 교반하였다. 이후 상기 혼합물에 가열된 실시예 1의 녹용 추출물 농축액을 0.52 kg을 넣고 약 2 내지 5분 동안 교반한 후 가열된 꿀을 10.5 kg을 넣고 균일하게 혼합될 때까지 약 20 내지 30분 동안 교반하였다. 그 다음 상기 혼합물을 중탕기에 배치된 항아리(토기)에 300 매쉬(mesh) 거름망을 통하여 균일하지 않게 남아있는 분말을 제거하며 투입하였다. 투입이 완료된 후 중탕기에 물을 채우고 90℃에서 72시간 동안 가열하고 냉각수 순환을 통하여 24시간 동안 냉각한 다음, 다시 90℃에서 24시간 동안 재가열하고 냉각수를 순환하여 24시간 동안 냉각한 후, 저온 숙성실에서 24시간 동안 숙성하여 실시예 2의 녹용경옥고를 제조하였다.1.4 kg of ginseng powder and 2.1 kg of bokryeong powder were put into a mixing container and mixed evenly, and then 14.9 kg of the juice from Rehmannia glutinosa was added through a sieve and stirred for about 20 to 30 minutes until lumps of powder disappeared. Thereafter, 0.52 kg of the heated antler extract concentrate of Example 1 was added to the mixture, stirred for about 2 to 5 minutes, and then 10.5 kg of heated honey was added and stirred for about 20 to 30 minutes until uniformly mixed. Then, the mixture was put into a pot (earthenware) placed in a water bath through a 300 mesh sieve while removing non-uniformly remaining powder. After the addition is complete, fill the water bath, heat at 90℃ for 72 hours, cool for 24 hours through cooling water circulation, reheat at 90℃ for 24 hours, circulate cooling water for 24 hours, and cool in a low-temperature aging room. Aged for 24 hours to prepare the antler jadeite of Example 2.
2) 2) 비교예comparative example 7 7
녹용경옥고 제조에 있어서, 상기 실시예 1의 녹용 추출물 농축액 대신 시판되는 녹용 분말을 사용한 것을 제외하고는 상기 실시예 2와 실질적으로 동일한 방법을 통해 비교예 7의 녹용경옥고를 제조하였다.Deer antler jadeite powder of Comparative Example 7 was prepared in substantially the same manner as in Example 2, except that commercially available deer antler powder was used instead of the antler extract concentrate of Example 1 in the preparation of antler jadeite powder.
(2) (2) 시험예test example . . 녹용경옥고에Deer antler jadeite 대한 관능검사 sensory test for
본 발명의 제조방법을 통해 제조된 녹용 추출물을 포함하는 녹용경옥고에 대한 관능검사를 지원자 성인 20명을 대상으로 수행하였다.A sensory test on antler jadeite extract containing the antler extract prepared by the manufacturing method of the present invention was performed on 20 adult volunteers.
구체적으로 녹용 관련 제품을 섭취한 경험이 있는 20명의 지원자에게 상기 실시예 2 및 비교예 7의 녹용경옥고를 섭취하게 하였으며, 식감 및 식향에 대해 5점 평점법에 따라 평가하였다. 평가기준은 하기와 같으며, 관능검사에 대한 결과(평균 점수)는 하기 표 5에 나타내었다.Specifically, 20 volunteers who had experience in eating deer antler-related products were allowed to consume the deer antler jadeite of Example 2 and Comparative Example 7, and the texture and taste were evaluated according to a 5-point scoring method. The evaluation criteria are as follows, and the results (average score) of the sensory test are shown in Table 5 below.
[평가 기준][Evaluation standard]
식감 - 5점: 매우 부드러움, 4점: 부드러움, 3점: 보통, 2점: 거칠거나 텁텁함, 1점: 매우 거칠거나 텁텁함 Texture - 5 points: very soft, 4 points: soft, 3 points: normal, 2 points: rough or chewy, 1 point: very rough or chewy
식향 - 5점: 특이취를 전혀 느낄 수 없음, 4점: 특이취 없는 편임, 3점: 보통, 2점: 특이취 인지 가능함, 1점: 특이취로 인해 섭취가 어려움 Taste - 5 points: No peculiar smell at all, 4 points: No peculiar smell, 3 points: Normal, 2 points: Perceptible peculiar smell, 1 point: Difficulty in intake due to peculiar smell
상기 표 5에서 확인할 수 있는 바와 같이, 본 발명의 제조방법에 의해 제조된 녹용 추출물을 포함하는 실시예 2는 녹용 분말을 사용한 비교예 7 대비 식감은 평균 4.25점으로 부드러움 이상의 긍정적인 평가를 받았다. 또한 식향 역시 평균 4.05점으로 녹용의 특이취가 없는 편이라는 긍정적인 평가를 받았다. 이는 본 발명의 제조방법에 의해 제조된 녹용 추출물을 사용하는 경우, 녹용경옥고 제조 시 포함되는 다른 원료들과의 혼합 숙성에 의하여 녹용 특이취가 중화되어 인지되지 않았으나, 녹용 분말을 사용한 경우 다른 원료들과 중화되지 못하고 녹용 특이취가 잔존하여 인지되는 것으로 여겨진다.As can be seen in Table 5, Example 2 containing the antler extract prepared by the manufacturing method of the present invention received an average of 4.25 points for texture compared to Comparative Example 7 using antler powder, receiving a positive evaluation of softness or more. In addition, the taste was also positively evaluated, with an average of 4.05 points, indicating that there is no specific smell of deer antler. This is because when using the antler extract prepared by the manufacturing method of the present invention, the specific odor of antler was neutralized by mixing and aging with other raw materials included in the production of antler jadeite, but it was not recognized. It is considered that it is recognized because it is not neutralized and the specific smell of antler remains.
Claims (4)
b) 상기 a) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계;
c) 상기 b) 단계에서 분리된 잔사물에 정제수 16 내지 18 L를 가한 후, 초음파 추출기를 이용하여 60 내지 80℃에서 8시간 동안 추출하는 단계;
d) 상기 c) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계;
e) 상기 d) 단계에서 분리된 잔사물에 정제수 16 내지 18 L를 가한 후, 120 내지 140℃에서 8시간 동안 추출하는 단계;
f) 상기 e) 단계에서 수득된 추출물을 여과하여 여과액 및 잔사물을 분리하는 단계; 및
g) 상기 b), d) 및 f) 단계에서 분리된 여과액을 혼합하는 단계;를 포함하는 녹용 추출물 제조방법.a) adding 16 to 18 L of 80% (v/v) alcohol to 3 to 4 kg of pulverized antler, and then extracting at 60 to 80° C. for 8 hours;
b) separating the filtrate and the residue by filtering the extract obtained in step a);
c) adding 16 to 18 L of purified water to the residue separated in step b) and extracting at 60 to 80 ° C. for 8 hours using an ultrasonic extractor;
d) separating the filtrate and the residue by filtering the extract obtained in step c);
e) adding 16 to 18 L of purified water to the residue separated in step d), followed by extraction at 120 to 140° C. for 8 hours;
f) filtering the extract obtained in step e) to separate a filtrate and a residue; and
g) mixing the filtrate separated in steps b), d) and f);
상기 a)와 b) 단계 사이, 상기 c)와 d) 단계 사이 및 상기 e)와 f) 단계 사이에 각각 4℃의 온도에서 숙성시키는 단계를 더 포함하는 녹용 추출물 제조방법.According to claim 1,
A method for producing an antler extract further comprising aging at a temperature of 4° C. between steps a) and b), between steps c) and d), and between steps e) and f).
상기 녹용 추출물은 우론산(uronic acid), 황산화 글리코사미노글리칸(sulfated-GAGs) 및 시알산(sialic acid)의 함량이 증진된 것인 녹용 추출물 제조방법.According to claim 1,
The method for preparing an antler extract, wherein the antler extract has increased contents of uronic acid, sulfated-GAGs, and sialic acid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200188765A KR102469337B1 (en) | 2020-12-31 | 2020-12-31 | Method for preparing antler extract and kyung-ok-go containing antler extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200188765A KR102469337B1 (en) | 2020-12-31 | 2020-12-31 | Method for preparing antler extract and kyung-ok-go containing antler extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220096379A KR20220096379A (en) | 2022-07-07 |
KR102469337B1 true KR102469337B1 (en) | 2022-11-21 |
Family
ID=82398746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200188765A KR102469337B1 (en) | 2020-12-31 | 2020-12-31 | Method for preparing antler extract and kyung-ok-go containing antler extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102469337B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102648841B1 (en) * | 2023-03-29 | 2024-03-21 | 주식회사 뉴트렉스테크놀러지 | A preparation method of deer antler extract with enhanced sialic acid content using ultra-high pressure |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101347516B1 (en) * | 2011-05-24 | 2014-01-03 | 에이치제이바이오팜 주식회사 | Method of preparing Gyoungokgo and Gyoungokgo prepared thereby |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100398487B1 (en) | 2001-07-13 | 2003-09-19 | 삼성전자주식회사 | Kimchi vessel |
KR20050090041A (en) | 2004-03-06 | 2005-09-09 | 안용근 | Method for extracting effective ingredients from hartshorn or antler |
-
2020
- 2020-12-31 KR KR1020200188765A patent/KR102469337B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101347516B1 (en) * | 2011-05-24 | 2014-01-03 | 에이치제이바이오팜 주식회사 | Method of preparing Gyoungokgo and Gyoungokgo prepared thereby |
Also Published As
Publication number | Publication date |
---|---|
KR20220096379A (en) | 2022-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1729874B (en) | Method for preparing composite powdered drink with mulberry leaf, mulberry and chrysanthemum flower | |
CN103392761B (en) | Giant knotweed rhizome and red jujube health-care bread | |
CN102302214A (en) | Honeysuckle, burdock, cassia seed and chrysanthemum beverage and production method thereof | |
CN103830496A (en) | Blood glucose reduction resistant composition | |
KR102042798B1 (en) | A method for preparing functional pills comprising extracts of natural materials | |
KR102469337B1 (en) | Method for preparing antler extract and kyung-ok-go containing antler extract | |
KR101812725B1 (en) | Manufacturing method for pills using medical plants comprising ginseng and pills using medical plants comprising ginseng manufactured by the same | |
KR102659842B1 (en) | Health functional food composition for improvement of bowel function and relief of contipation comprising psyllium husk and complex extract, and manufacturing method thereof | |
KR101507692B1 (en) | Manufacturing method of prickly pear undiluted liquid and undiluted liquid using the manufacturing method | |
WO2005062713A2 (en) | Beta vulgaris-based products | |
CN114515005B (en) | Coix seed extract containing chrysanthemum components and preparation method and application thereof | |
KR101834638B1 (en) | The method of functional korea traditional cracker using the jujube | |
KR101015025B1 (en) | Apple beverage containing acanthopanax extract and manufacturing process of the same | |
KR102485556B1 (en) | Protension holding method, an extraction method of protein hydrolysis antler to increase the efficiency of extracting active ingredients from antlers | |
CN105087284B (en) | A kind of compound raspberry health preserving wine and preparation method thereof | |
CN104207286A (en) | Liver protection Chinese herbal medicine healthcare vinegar drink | |
RU2370103C1 (en) | Preparation of jam out of seaweed | |
CN104225573A (en) | Composition with blood sugar and blood lipid reducing function and preparation method of composition | |
CN106222012A (en) | A kind of fig wine alleviating rheumatism | |
KR20220000658A (en) | Manufacturing method of Liquor for Enhancement of Level of Immunity | |
CN110786485A (en) | Jasmine black currant jam and preparation method thereof | |
KR102627679B1 (en) | Manufacturing method of Beverage containing Vitis vinifera and Blueberry | |
KR100753644B1 (en) | Processing method of houttuynia cordata and saururus ohinesis and processed food therefrom | |
CN108741046A (en) | A kind of tamarind crystal beer cake and preparation method thereof | |
KR102264978B1 (en) | Method for producing pear puree showing the effect of improving dysuria |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |